Keshab Rijal

707 total citations
14 papers, 504 citations indexed

About

Keshab Rijal is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Keshab Rijal has authored 14 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Keshab Rijal's work include RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (6 papers). Keshab Rijal is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (6 papers). Keshab Rijal collaborates with scholars based in United States, Japan and France. Keshab Rijal's co-authors include Richard J Maraia, Gopalakrishnan Aneeshkumar Arimbasseri, Christine S. Chow, James Iben, Fan‐Yan Wei, Kazuhito Tomizawa, Markus Hafner, Xun Bao, Vipul C. Chitalia and Katya Ravid and has published in prestigious journals such as Nucleic Acids Research, Chemical Communications and Journal of the American Society of Nephrology.

In The Last Decade

Keshab Rijal

14 papers receiving 500 citations

Peers

Countries citing papers authored by Keshab Rijal

Since Specialization

Citations

This map shows the geographic impact of Keshab Rijal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keshab Rijal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keshab Rijal more than expected).

Fields of papers citing papers by Keshab Rijal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keshab Rijal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keshab Rijal. The network helps show where Keshab Rijal may publish in the future.

Co-authorship network of co-authors of Keshab Rijal

This figure shows the co-authorship network connecting the top 25 collaborators of Keshab Rijal. A scholar is included among the top collaborators of Keshab Rijal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keshab Rijal. Keshab Rijal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Diagnostic value of pleural cholesterol in differentiating exudative and transudative pleural effusion 2022 ·Annals of Medicine and Surgery ·(unknown), (unknown), Binita Bhattarai, (unknown), (unknown), (unknown), Keshab Rijal, (unknown)	3
2	Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans 2018 ·Journal of the American Society of Nephrology ·Vijaya B. Kolachalama, Moshe Shashar, (unknown), Sowmya Shivanna, Keshab Rijal, Mostafa Belghasem, Joshua Walker, Shinobu Matsuura, Gary H. Chang, C. Michael Gibson, Laura M. Dember, Jean Francis, Katya Ravid, Vipul C. Chitalia	77
3	A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum 2017 ·Journal of Biological Methods ·Anqi Zhang, Keshab Rijal, (unknown), Katya Ravid, Vipul C. Chitalia	19
4	Lack of tRNA-i6A modification causes mitochondrial-like metabolic deficiency in S. pombe by limiting activity of cytosolic tRNA^Tyr, not mito-tRNA 2016 ·RNA ·Tek N. Lamichhane, Gopalakrishnan Aneeshkumar Arimbasseri, Keshab Rijal, James Iben, Fan‐Yan Wei, Kazuhito Tomizawa, Richard J Maraia	32
5	Evolving specificity of tRNA 3-methyl-cytidine-32 (m³C32) modification: a subset of tRNAs^Ser requires N⁶-isopentenylation of A37 2016 ·RNA ·Gopalakrishnan Aneeshkumar Arimbasseri, James Iben, Fan‐Yan Wei, Keshab Rijal, Kazuhito Tomizawa, Markus Hafner, Richard J Maraia	69
6	Active Center Control of Termination by RNA Polymerase III and tRNA Gene Transcription Levels In Vivo 2016 ·PLoS Genetics ·Keshab Rijal, Richard J Maraia	13
7	A methods review on use of nonsense suppression to study 3′ end formation and other aspects of tRNA biogenesis 2014 ·Gene ·Keshab Rijal, Richard J Maraia, Gopalakrishnan Aneeshkumar Arimbasseri	15
8	Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation 2013 ·Transcription ·Gopalakrishnan Aneeshkumar Arimbasseri, Keshab Rijal, Richard J Maraia	64
9	Amino acid-linked platinum(ii) analogues have altered specificity for RNA compared to cisplatin 2013 ·Chemical Communications ·Keshab Rijal, Xun Bao, Christine S. Chow	27
10	RNA polymerase III mutants in TFIIFα-like C37 that cause terminator readthrough with no decrease in transcription output 2012 ·Nucleic Acids Research ·Keshab Rijal, Richard J Maraia	31
11	Transcription termination by the eukaryotic RNA polymerase III 2012 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Gopalakrishnan Aneeshkumar Arimbasseri, Keshab Rijal, Richard J Maraia	87
12	Point mutations in the Rpb9-homologous domain of Rpc11 that impair transcription termination by RNA polymerase III 2011 ·Nucleic Acids Research ·James Iben, (unknown), Samuel A. Hasson, Keshab Rijal, Gopalakrishnan Aneeshkumar Arimbasseri, (unknown), Richard J Maraia	30
13	Exploring potential drug target sites in the ribosome using cisplatin and its analogues 2011 ·DigitalCommons - WayneState (Wayne State University) ·Keshab Rijal	1
14	A new role for cisplatin: probing ribosomal RNA structure 2008 ·Chemical Communications ·Keshab Rijal, Christine S. Chow	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact